Susquehanna International Group
ORGS

Susquehanna International Group’s Orgenesis Inc. Common Stock ORGS Stock Holding History

Susquehanna International Group’s Portfolio ORGS Stock Details ORGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,550
Closed -$77K – 14093
2021
Q3 		$77K Buy
+1,550
New +$77.8K ﹤0.01% 12192

Other funds holding ORGS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BHB
Bank Hapoalim BM Tel Aviv, Israel $652M AUM 19.01% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
CD
Chapin Davis Baltimore, Maryland $569M AUM 145.59% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Susquehanna International Group's ORGS Position: Q4 2022 in Review

Susquehanna International Group sold out of Orgenesis Inc. Common Stock (ORGS) in Q4 2022, closing a stake of 2,927 shares — an estimated $42K sold.

Susquehanna International Group first reported a position in ORGS in Q3 2019 and held it in 3 quarters. The position peaked at $58K in Q3 2019. 20 funds tracked by Wall St. Rank hold ORGS as of Q4 2022.

  • Susquehanna International Group reported no remaining Orgenesis Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Susquehanna International Group sold 2,927 Orgenesis Inc. Common Stock shares in Q4 2022, an estimated $42K.
  • Susquehanna International Group first reported a position in Orgenesis Inc. Common Stock in Q3 2019 and held it in 3 quarters.
  • Susquehanna International Group's Orgenesis Inc. Common Stock position peaked at $58K in Q3 2019.
  • 20 funds tracked by Wall St. Rank held Orgenesis Inc. Common Stock as of Q4 2022.

Based on Susquehanna International Group's 13F filing for Q4 2022, filed 14 Feb 2023.